Phase I Trial of Escalating Doses of BNP7787 in Patients With Solid Tumors Undergoing Treatment With Cisplatin and Taxol
Sponsor study identifier
Secondary identifiers
observational
2
1 country
3
Study Start
March 1998
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2003
Actual (reported)Study Completion
Not reported
Date not reportedRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs such as dimesna may protect normal cells from the side effects of chemotherapy. PURPOSE: This phase I trial is studying the side effects and best dose of dimesna in treating patients with solid tumors who are receiving cisplatin and paclitaxel.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 1998
Date type not reportedThis date has not been verified as actual or estimated.
November 1, 1999
Actual (reported)January 27, 2003
Actual (reported)June 2003
Actual (reported)University of Chicago Cancer Research Center
Chicago, Illinois, 60637-1470, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231-2410, United States
Roswell Park Cancer Institute
Buffalo, New York, 14263-0001, United States
Patrick J. Creaven, MBBS, PhD
Roswell Park Cancer Institute
2 participants (actual enrollment reported by the registry).
First Submitted
November 1, 1999
First Posted
January 27, 2003
Study Start
March 1998
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
June 2003
Actual (reported)Last Updated
January 31, 2013
Record last verified: 2013-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: